FDA panel to review Novavax vaccine as potential fourth shot for adult Americans, and Pete Buttigieg tests positive for COVID
June 07, 2022 at 10:16 AM EDT
An advisory panel to the U.S. Food and Drug Administration is due to meet later Tuesday to review the vaccine developed by Novavax Inc. as a potential fourth shot for American adults and will vote on whether the risks outweigh the benefits.